Compositions and Methods for Treating Mycobacterium Infections
Summary
USPTO published patent application US20260091043A1 for compositions and methods treating infections caused by Mycobacteriaceae family pathogens, including those causing tuberculosis. Inventors John David Wild, Jeremy Joseph Yang, and Sean Ekins filed the application on September 20, 2023. The application claims priority to Application No. 19113756 and covers novel therapeutic approaches to bacterial infections.
What changed
USPTO published patent application US20260091043A1 titled 'Compositions and Methods for Treating Mycobacterium Infections.' The application discloses treatments for infections caused by pathogenic bacteria within the Mycobacteriaceae family, with CPC classifications A61K 31/609, A61P 31/04, and A61P 31/06 indicating pharmaceutical compositions for antibacterial and anti-tubercular applications. The application was filed on September 20, 2023, under Application No. 19113756 and published on April 2, 2026.
Patent applications do not impose compliance obligations on third parties. Drug manufacturers and pharmaceutical researchers may review this publication to understand potential new therapeutic approaches being developed. Healthcare providers and biotechnology companies should note this disclosure when conducting related R&D to avoid potential infringement issues during product development.
Archived snapshot
Apr 3, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS
Application US20260091043A1 Kind: A1 Apr 02, 2026
Inventors
John David WILD, Jeremy Joseph YANG, Sean EKINS
Abstract
Described herein are treatments of infections and diseases caused by pathogenic bacteria, including the treatment of infections and diseases caused by Mycobactertaceae.
CPC Classifications
A61K 31/609 A61P 31/04 A61P 31/06
Filing Date
2023-09-20
Application No.
19113756
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.